Diabetes Clinical Trial
Official title:
Predictive and Protective Factors in the Cause of Diabetes: A Study in Twins
This study, conducted at St. Bartholomew's Hospital, London, England, will determine whether
cells passed from mother to offspring during pregnancy increase or decrease the child's risk
of developing type 1 diabetes. Previous research has shown that certain cells that can be
passed from mothers to their children during pregnancy may affect the child's chance of
developing other autoimmune diseases. The cells from the mother may persist in the child's
blood for years after birth and stimulate the child's immune system in such a way that may
either increase or decrease the chance of the child developing diabetes. This study will
determine whether these cells are present in identical twins, where only one of the twins
has type 1 diabetes.
Participants in the British Diabetic Twins Study in England may be eligible to participate.
Of each twin pair in the study, one must have type 1 diabetes and the other must be free of
the disease. The twins' mother must be alive and willing to provide a blood sample. For
female twins only, their children must be alive and willing to provide either a blood or a
buccal cell sample (cheek swab).
Participants undergo the following procedures:
- Both twins in each twin pair provide a blood sample collected on a single occasion.
- The mother of each twin pair provides a blood sample collected on a single occasion.
- Children of female twins provide a single sample from either the mouth or blood. For
children younger than 12 years of age, a cell sample is collected from the inside of
the mouth (buccal) using a toothbrush. The child strokes the inside (cheek) of the
mouth with the toothbrush ten times on each side, spits this into a collection vial,
immediately rinses the mouth with water and adds this rinse to the sample collection
vial. Children over 12 years of age may provide either a buccal cell sample or a blood
sample.
Type 1 diabetes is one of several autoimmune diseases of unclear etiology in which the
discordance rate between identical twins is between 30-40%, even after many years of
follow-up. This intermediate discordance rate indicates that there are clearly genetic
factors at play in susceptibility to type 1 diabetes, with most genetic contribution coming
from the HLA locus. However, this discordance rate also means that other, non-genetic
factors, possibly environmental, lead to the development of disease in only one of two
genetically identical individuals. No consensus exists on the nature of these putative
environmental differences, which are all the more remarkable for occurring in twins that
generally share the same intrauterine, family and school environment.
Recent evidence has suggested that the development of certain autoimmune diseases,
particularly scleroderma, may be influenced by microchimerism: Both fetomaternal
microchimerisms (persistence of fetal cells in the maternal circulation after birth of the
child) and maternofetal microchimerism (persistence of maternal cells in the child's
circulation for years after birth) have been suggested as creating an abnormal environment
that might stimulate the development of autoimmunity in genetically susceptible individuals.
The reverse is also possible, i.e., that these abnormal cells may stimulate the immune
system in such a way that autoimmunity does not develop.
Identical or monozygotic (MZ) twins who are discordant for type 1 diabetes offer a unique
experimental model in which to test the hypothesis that quantitative differences in
persistent maternofetal microchimerism influence the development of type 1 diabetes in these
genetically susceptible individuals. This study will use pairs of MZ twins discordant for
the type 1 diabetes that are already participating in the British Diabetic Twins Study being
conducted by Dr. David Leslie at St. Bartholomew's Hospital in London, UK. If the mothers of
the twins (both female and male) and offspring of the female twins (only) are available for
study, they will be asked to provide a single blood sample (twins, mothers, offspring
greater than 12 years of age) or buccal cell sample (offspring less than or equal to 12
years of age) from which DNA will be purified. This is to confirm the origin of the chimeric
cells; since cells are passed from the mothers to the offspring during pregnancy, we require
(DNA) samples from the mothers of all twins (male and female) who participate in this study.
But since the opposite is true, that cells can also be passed from offspring to their
mothers during pregnancy, we will require (DNA) samples from the female twins' offspring to
determine the true origin of any chimeric cells. The DNA will be used for HLA genotyping to
identify nonshared HLA alleles that can be used to develop specific assays for the
persistence of maternal DNA in the twins' circulation and quantitative PCR of the mother's
genotype in CD3+ cells isolated from the twins. Since trafficking of chimeric cells can be
bi-directional, twins who have had offspring of their own may have chimeric cells of both
fetal and maternal origin in their circulation. To confirm the origin of the chimeric cells,
the blood or buccal cells collected from the offspring of the twins will be genotyped and
these compared to the genotypes of the twins' mothers. Blood will be drawn and DNA purified
by Dr. Leslie's group in London; the genotyping and quantitative PCR will be performed by
Dr. Artlett's group at Thomas Jefferson University, Philadelphia, which has been studying
microchimerism since 1998. Results of the study may provide evidence in support of
microchimerism as an influential factor in the development of type 1 diabetes. Evidence in
support to this concept would be an important addition to the literature on "environmental"
factors that influence type 1 diabetes etiology, and also suggest potential
immunosuppression or other strategies in type 1 diabetes prevention.
;
N/A
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05594446 -
Morphometric Study of the Legs and Feet of Diabetic Patients in Order to Collect Data Intended to be Used to Measure by Dynamometry the Pressures Exerted by Several Medical Compression Socks at the Level of the Forefoot
|
||
Completed |
NCT03975309 -
DHS MIND Metabolomics
|
||
Completed |
NCT01855399 -
Technologically Enhanced Coaching: A Program to Improve Diabetes Outcomes
|
N/A | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Recruiting |
NCT04984226 -
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
|
Phase 2 | |
Recruiting |
NCT05007990 -
Caregiving Networks Across Disease Context and the Life Course
|
||
Active, not recruiting |
NCT04420936 -
Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program
|
N/A | |
Recruiting |
NCT03549559 -
Imaging Histone Deacetylase in the Heart
|
N/A | |
Completed |
NCT04903496 -
Clinical Characteristics and Disease Burden of Diabetic Patients Based on Tianjin Regional Database
|
||
Completed |
NCT01437592 -
Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT03390179 -
Hyperglycemic Response and Steroid Administration After Surgery (DexGlySurgery)
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Recruiting |
NCT05294822 -
Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes
|
N/A | |
Completed |
NCT04427982 -
Dance and Diabetes/Prediabetes Self-Management
|
N/A | |
Completed |
NCT02356848 -
STEP UP to Avert Amputation in Diabetes
|
N/A | |
Completed |
NCT03292185 -
A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects
|
Phase 1 | |
Active, not recruiting |
NCT05477368 -
Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes
|
N/A | |
Completed |
NCT04496401 -
PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus
|
Phase 4 |